全部股東
股東類型
- 公眾及其他63.13%
- 個人與內幕人士16.33%
- 僱員持股計劃10.59%
- 創投/私募8.43%
- 機構投資者1.52%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Wenzhi TianFounder, CEO, Chief Scientific Officer & Chairman of the Board | 16.33% | 7,048.30 萬 | 0.01% | +5.00 萬 | 19/05/2026 |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP | 10.59% | 4,570.11 萬 | 0.00% | +0 | 19/05/2026 |
Shanghai Yongkan Investment Management Co., Ltd. | 8.43% | 3,639.23 萬 | 0.00% | +0 | 31/12/2025 |
GF Fund Management Co., Ltd. | 0.76% | 327.72 萬 | 0.00% | +0 | 30/06/2025 |
E Fund Management Co., Ltd. | 0.41% | 178.04 萬 | 0.00% | +0 | 30/06/2025 |
State Street Investment Management | 0.23% | 97.58 萬 | <0.01% | +3.66 萬 | 31/08/2026 |
Zhong Ou Fund Management Co., Ltd | 0.09% | 39.90 萬 | 0.00% | +0 | 30/06/2025 |
Fullgoal Fund Management Co. Ltd. | 0.02% | 8.86 萬 | 0.00% | +0 | 31/12/2025 |
Dimensional Fund Advisors LP | <0.01% | 1.88 萬 | <0.01% | +2,067.00 | 30/04/2026 |